Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
19.02
+0.37 (+1.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
The Latest Analyst Ratings for NovoCure
June 06, 2023
Via
Benzinga
Nasdaq Edges Higher; Joann Shares Plummet
June 06, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also...
Via
Benzinga
Why NovoCure Stock Is Crashing Today
June 06, 2023
Analysts weren't wowed by the company's late-stage data.
Via
The Motley Fool
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
June 06, 2023
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
June 06, 2023
Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients.
Via
Investor's Business Daily
NovoCure's Return On Capital Employed Overview
May 18, 2023
Via
Benzinga
4 Analysts Have This to Say About NovoCure
May 16, 2023
Via
Benzinga
Should You Buy Novocure Stock Right Now?
May 05, 2023
Most Wall Street analysts think this stock will skyrocket. They could be right.
Via
The Motley Fool
NovoCure (NVCR) Q1 2023 Earnings Call Transcript
May 04, 2023
NVCR earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Dow Drops 50 Points; J.M. Smucker Earnings Top Views
June 06, 2023
U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,...
Via
Benzinga
3 No-Brainer Stocks to Buy for Under $100 Right Now
May 27, 2023
These stocks might not remain under $100 for too much longer.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
Novocure Stock Dips As Q1 Earnings Miss Estimates, Higher Costs Hurt Bottom Line
May 04, 2023
Via
Benzinga
NovoCure: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About NovoCure
March 17, 2023
Via
Benzinga
2 Best Defensive Stocks to Buy in March
March 08, 2023
These two defensive stocks should shine in the event of a marketwide correction.
Via
The Motley Fool
NovoCure Earnings Perspective: Return On Capital Employed
February 27, 2023
Via
Benzinga
The 3 Most Promising Healthcare Tech Stocks for April 2023
April 26, 2023
The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
2 Stocks That Could Rebound and Rise 30% or More in 2023
March 10, 2023
They're down, but they aren't yet out.
Via
The Motley Fool
Why NovoCure Stock Is Falling Today
February 23, 2023
Investors were looking for a stronger Q4 from the cancer company.
Via
The Motley Fool
NovoCure (NVCR) Q4 2022 Earnings Call Transcript
February 23, 2023
NVCR earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Novocure Stock Was so Healthy Today
February 15, 2023
There was good news from the laboratory on Hump Day.
Via
The Motley Fool
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Why Novocure Stock Is Sliding Today
January 19, 2023
Investors reacted negatively to the oncology treatment specialist's game of C-suite musical chairs.
Via
The Motley Fool
Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes
January 19, 2023
A series of unexpected C-suite changes sent shares diving again.
Via
Investor's Business Daily
Will Novocure Stock Sink or Soar in 2023?
January 19, 2023
The stock has both soared and sank already this year.
Via
The Motley Fool
Novocure Has Fallen More Than 20% Over Seven Days — Why It Fell From Grace
January 17, 2023
Shares have given back a chunk of their 69% single-day gain on a lung cancer study.
Via
Investor's Business Daily
Why Novocure Stock Is Sinking Today
January 09, 2023
The company provided a disappointing sneak peek at its Q4 results.
Via
The Motley Fool
Is NovoCure a Good Stock to Buy Right Now?
January 07, 2023
Successful clinical trial results recently pushed this stock more than 68% higher overnight -- but what about the road ahead?
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.